Sleep Sleep quality and weight are directly connected
Implications and Future Research GLP-1 agonists offer significant benefits for weight loss and metabolic health, but their potential effects on sexual function should not be overlooked
Tirzepatide: a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) dual agonist in development for the treatment of type 2 diabetes
After 12 months, this therapy resulted in weight improvement, with a weight loss of 10 kg and a BMI reduction from 30 to 26.4 kg/m, and better glycemic control, as demonstrated by a reduction in HbA1c levels (7.4%)
The report, published by a team from the David Geffen School of Medicine at UCLA, details cases where these incretin-based therapies triggered sensory disturbances known as dysesthesia and allodynia
In T 1 DM, an autoimmune mechanism impairs -cells, leading to insulin deficiency, whereas T 2 DM is characterized by insulin resistance and impaired glucose regulation, where the peripheral action of insulin is compromised (3)